← Eichor
Condition: Dose Finding Study Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Dose Finding Study

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Parti
Phase 2 · 8 location(s) · ModernaTX, Inc. · NCT07561294Dose-Finding Study: MEV90 for Local Anesthetic in Interscalene Block for Supraclavicular Nerves Block
NA · 1 location(s) · Hospital del Trabajador de Santiago · NCT07338916Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated A
Phase 1 · 7 location(s) · Tenaya Therapeutics · NCT06228924Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
Phase 1 · 1 location(s) · Theolytics Limited · NCT07211659A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Phase 1/Phase 2 · 45 location(s) · Eli Lilly and Company · NCT06721013A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers
Phase 1 · 7 location(s) · Light Chain Bioscience - Novimmune SA · NCT05403554Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/
Phase 1/Phase 2 · 14 location(s) · Ellipses Pharma · NCT05573126Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions
NA · 1 location(s) · NHS Greater Glasgow and Clyde · NCT07372508A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Parti
Phase 1 · 3 location(s) · Comanche Biopharma · NCT07282171A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Benefi
Phase 1/Phase 2 · 68 location(s) · BioNTech SE · NCT07111520A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · 10 location(s) · Flare Therapeutics Inc. · NCT07719361An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of th
Phase 2/Phase 3 · 1 location(s) · SyneuRx International (Taiwan) Corp · NCT03094429A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Phase 2 · 1 location(s) · Chiesi Farmaceutici S.p.A. · NCT07516951A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works
Phase 1/Phase 2 · 11 location(s) · Regeneron Pharmaceuticals · NCT06413680A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult
Phase 1/Phase 2 · 61 location(s) · Bristol-Myers Squibb · NCT06618287A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Livi
Phase 2 · 147 location(s) · Novo Nordisk A/S · NCT06717698A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Phase 2 · 39 location(s) · Swedish Orphan Biovitrum · NCT06782373Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxe
Phase 1/Phase 2 · 4 location(s) · Onconic Therapeutics Inc. · NCT05257993A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT06529432A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS
Phase 1 · 19 location(s) · Children's Oncology Group · NCT06247787Oral Immunotherapy for Peanut Allergic Patients
Phase 1/Phase 2 · 2 location(s) · InnoUp Farma S.L. · NCT04163562Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants
Phase 1/Phase 2 · 3 location(s) · Instituto de Investigación Hospital Universitario La Paz · NCT06878742A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Hi
Phase 1/Phase 2 · 3 location(s) · University of Southern California · NCT04333706Study of TRX-920 for Patients With Advanced Solid Tumors
Phase 1 · 3 location(s) · TaiRx, Inc. · NCT06143774Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
Phase 1/Phase 2 · 1 location(s) · M.R. Meijerink · NCT06630624A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymph
Phase 1/Phase 2 · 67 location(s) · Bristol-Myers Squibb · NCT06090539A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants
Phase 1 · 5 location(s) · Insmed Gene Therapy LLC · NCT07290062A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Phase 2 · 52 location(s) · Takeda · NCT06952699Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years
Phase 1/Phase 2 · 7 location(s) · Sanofi · NCT06891417A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Phase 2 · 45 location(s) · Corxel Pharmaceuticals · NCT07340320
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.